期刊文献+

重症酒精性肝炎需要关注的几个问题 被引量:5

Ssevere alcoholic hepatitis: some current challenges and future directions
下载PDF
导出
摘要 重症酒精性肝炎(severe alcoholic hepatitis,SAH)是肝脏的一种无菌性炎症性损伤,大多发生在慢性肝病(脂肪肝、肝硬化)的基础上,因短期内大量饮酒所致肝病的急性恶化,是酒精性肝病(alcoholic liver disease,ALD)严重的表现形式。多数起病急骤,出现高度黄疸和严重凝血功能障碍等,迅速进展为肝功能衰竭、败血症和其他器官功能障碍(尤其是肝肾综合征),短期病死率接近40%[1],但不少临床医生还缺乏对SAH的早期识别和及时处理的经验。在本期相关文章中已经就ALD发病机制、诊断以及治疗问题进行了阐述,本文就几个容易被忽略的问题展开讨论,提请大家关注。
作者 王炳元
出处 《实用肝脏病杂志》 CAS 2014年第1期3-4,共2页 Journal of Practical Hepatology
关键词 酒精性肝炎 狂饮 肝活检 糖皮质激素 己酮可可碱 Severe alcoholic hepatitis Spree Liver biopsy Corticosteroids Pentoxifylline
  • 相关文献

参考文献11

  • 1Verma S,Ajudia K,Mendler M. Prevalence of septic events,type 1 hepatorenal syndrome,and mortality in severe alcoholic hepatitis and utility of discriminant function and MELD score in predicting these adverse events[J].{H}Digestive Diseases and Sciences,2006,(09):1637-1643.
  • 2O'Shea RS,Dasarathy S,McCullough AJ,Practice Guideline Committee of the American Association for the Study of Liver Diseases,Practice Parameters Committee of the American College of Gastroenterology. Alcoholic liver disease[J].{H}HEPATOLOGY,2010,(01):307-328.
  • 3刘鹏亮,王炳元.青少年脂肪肝:狂饮与肥胖[J].实用肝脏病杂志,2012,15(3):189-190. 被引量:6
  • 4Xu J,Lai KK,Verlinsky A. Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK[J].{H}Journal of Hepatology,2011,(03):673-682.
  • 5Novo E,Parola M. Redox mechanisms in hepatic chronic wound healing and fibrogenesis[J].Fibrog Tis Rep,2008,(01):5.
  • 6Tolstrup JS,Grnbaek M,Tybjaerg-Hansen A. Alcohol in-take,alcohol dehydrogenase genotypes,and liver damage and disease in the Danish general population[J].{H}American Journal of Gastroenterology,2009,(09):2182-2188.
  • 7Potts JR,Verma S. Alcoholic hepatitis:diagnosis and manage-ment in 2012[J].Expert Rev Gastroenterol Hepatol,2012,(06):695-710.
  • 8王菲,郑娉娉,王炳元,王柏芳,马力,丁媛媛,李金萍,王颖.酒精性肝硬化患者的临床特征[J].传染病信息,2011,24(5):271-274. 被引量:19
  • 9Atar E,Ben Ari Z,Bachar GN. A comparison of tran-sjugular and plugged-percutaneous liver biopsy in patients with contraindications to ordinary percutaneous liver biopsy and an"in-house” protocol for selecting the procedure of choice[J].Car-diovasc Intervent Radiol,2010,(03):560-564.
  • 10王炳元,傅宝玉,李异玲.酒精戒断综合征的鉴别诊断与治疗[J].中国医科大学学报,2000,29(1):78-78. 被引量:26

二级参考文献23

  • 1中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南[J].传染病信息,2005,18(z1):1-12. 被引量:467
  • 2中华医学会肝病学分会脂肪肝和酒精性肝病学组.酒精性肝病诊疗指南[J].中国肝脏病杂志(电子版),2010,2(4):49-53. 被引量:385
  • 3王炳元,孔琪,傅宝玉.血清转铁蛋白微小变异的测定及其临床意义[J].肝脏病杂志,1995,3(4):214-215. 被引量:16
  • 4Morrison DS,Boyd AA,Richardson T. Liver cirrhosis mortality rates in Britain.Lancet,2006,367(9526):1899.
  • 5Mathurin P,Dehenre P. Effect of binge drinking on the liver: an alarming public health issue? Gut,2009,58(5):613-617.
  • 6McCarty CA,Ebel BE,Garrison MM,et al. Continuity of binge and harmful drinking from late adolescence to early adulthood. Pediatrics, 2004, 114( 3 ):714-719.
  • 7Larsson SC,Wolk A.Overweight,obesity and risk of liver can- cer: a meta-analysis of cohort studies. Br J Cancer,2007,97 (7):1005-1008.
  • 8Hasin D,Fenton MC,Skodol A,et al.Personality disorders and the 3-year course of alcohol,drug,and nicotine use disorders. Arch Gen Psychiatry,2011,68( 11 ):1158-1167.
  • 9Xu J,Lai KK,Verlinsky A,et al.Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK. J Hepatol, 2011,55(3):673-82.
  • 10Novo E,Parola M. Redox. mechanisms in hepatic chronic wound healing and fibrogenesis. Fibrogenesis Tissue Repair, 2008,1 ( 1 ):5.

共引文献62

同被引文献55

  • 1Tawfik Khoury,Ayman Abu Rmeileh,Liron Yosha,Ariel A.Benson,Saleh Daher,Meir Mizrahi.Drug Induced Liver Injury: Review with a Focus on Genetic Factors, Tissue Diagnosis, and Treatment Options[J].Journal of Clinical and Translational Hepatology,2015,3(2):99-108. 被引量:20
  • 2Christin Giordano,John Rivas,Xaralambos Zervos.An Update on Treatment of Drug-Induced Liver Injury[J].Journal of Clinical and Translational Hepatology,2014,2(2):74-79. 被引量:11
  • 3中华医学会肝病学分会脂肪肝和酒精性肝病学组.酒精性肝病诊疗指南[J].中国肝脏病杂志(电子版),2010,2(4):49-53. 被引量:385
  • 4郑宋明,郑晶晶,雷后兴.畲药对慢性乙型肝炎生化指标及HBeAg HBV-DNA的影响[J].中华中医药学刊,2007,25(8):1660-1661. 被引量:6
  • 5Marik PE, Gayowski T,Starl TE. The hepatoadrenal syndrome: acommon yet unrecognized clinical condition. Cri Care Med, 2005,33: 1254 -1259.
  • 6Papatheodoridis GV,Manolakopoulos S,Dusheiko G, et al.Therapeutic strategies in the management of patients with chronichepatitis B virus infection . Lancet Infect Dis, 2008,8: 167-178.
  • 7Schuurhuis DH, loan-Facsinay A, Nagelkerken B, et al. Antigen-antibody immune complexes empower dendritic cells to efficientlyprime specific CD8 + CTL responses in vivo. J Immunol, 2002,168: 2240-2246.
  • 8Fernandez J, Escorsell A,Zabalza M , et al. Adrenal insufficiency inpatients with cirrhosis and septic shock: effect of treatment withhydrocortisone on survival. Hepatology, 2006,44: 1288-1295.
  • 9Zhang XQ. Jiang L,You JP, et al. Efficacy of short termdexamethasone therapy in acute-on-chronic preliver failure.Hepatol Res,2011, 41: 46-53.
  • 10Fujiwara K1,Yasui S,Yonemitsu Y, et al. Efficacy of combinationtherapy of antiviral and immunosuppressive drugs for the treatmentof severe acute exacerbation of chronic hepatitis B. J Gastroenterol.2008,43:711-719.

引证文献5

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部